0001104659-26-014300
SEC filingMobileye Global Inc. (MBLY) reported FY 2025 revenue of $1.89B, with gross profit of $904.0M reflecting a gross margin of approximately 47.8%. Despite revenue generation, the company posted an operating loss of -$440.0M driven by elevated research and development expenses of $1.15B, which comprised the bulk of total operating expenses at $1.34B. Net loss stood at -$392.0M after a $15.0M tax benefit and $63.0M financial income. Balance sheet remains robust with $12.49B total assets, including $1.84B cash and equivalents, $8.20B goodwill, and $11.88B equity, yielding a strong liquidity position. Cash flow from operations was positive at $602.0M, supporting a $422.0M increase in cash despite $91.0M investing outflows and $106.0M financing uses. No prior year figures are disclosed in the filing, limiting YoY analysis. The persistent operating losses highlight heavy investment in R&D amid competitive ADAS and autonomy markets, but substantial cash reserves and positive operating cash flow provide runway for growth initiatives without immediate liquidity concerns.
Mobileye Global Inc. reported FY 2025 results ending December 27, 2025, with revenue of $1.89B and gross profit of $904.0M after $990.0M cost of revenue. Operating expenses totaled $1.34B, including $1.15B research and development (net), $113.0M sales and marketing, and $80.0M general and administrative, resulting in an operating loss of -$440.0M. Financial income net of $63.0M and a $15.0M tax benefit led to net loss of -$392.0M. Total comprehensive loss was -$377.0M after $15.0M other comprehensive income. Balance sheet shows total assets of $12.49B, with total liabilities $611.0M and equity $11.88B. No prior period comparisons are provided in the filing. Earnings per share basic and diluted reported as -$0, with weighted average shares of 813.0M.
Revenue for FY 2025 was $1.89B. No segment breakdowns, geographic mix, or growth drivers are disclosed in the provided filing data. Cost of revenue was $990.0M, yielding gross profit of $904.0M.
Gross margin calculated as $904.0M / $1.89B ≈ 47.8%. Operating margin was -$440.0M / $1.89B ≈ -23.3%, pressured by high R&D at $1.15B (61% of revenue). No goodwill impairment recorded ($0). Total operating expenses of $1.34B represent 71% of revenue. Share-based compensation contributed $277.0M to expenses, with amortization of intangibles at $443.0M in cash flow adjustments.
Net cash from operating activities was $602.0M, driven by non-cash items including $443.0M intangible amortization, $277.0M share-based compensation, and $74.0M depreciation, plus working capital changes like -$89.0M inventory increase. Investing activities used -$91.0M net, mainly $79.0M property purchases and net $12.0M investment outflows. Financing used -$106.0M, including $100.0M stock repurchase from parent. Cash increased $422.0M to $1.84B cash equivalents (restricted cash end balance $1.03B noted). Total current assets $2.48B vs. current liabilities $406.0M provide strong liquidity; no debt disclosed.
No management guidance, strategic priorities, or risk factors are explicitly disclosed in the provided filing excerpt.